SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SGHT

Sight Sciences, Inc. (NASDAQ:SGHT)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$10.18-$0.44 (-4.14%)
 
Market cap
$566M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 15, 2021
Market Cap$565.79M+35.9%
Revenue (ttm)$88.39M+16.2%
Net Income-$28.40M+38.4%
EPS-$0.52+42.4%
Shares Out55.58M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume369,606
Open$10.70
Previous Close$10.62
Day's Range$9.97 - $10.70
52-Week Range$3.38 - $11.60
Beta2.40
AnalystsBuy
Price Target$10.50(+3.14%)
Earnings DateMar 3, 2027

About SGHT

Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.

Address
4040 Campbell Avenue, Menlo Park, CA, 94025, US
Market Cap
566 million
Employees
186
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.70M
Bought
$68.81K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
2 Buy1 Hold0 SellAvg target $8.50 (-16.5%)

3 firms rating SGHT in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From SGHT’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-4.14%
5 Days
-5.91%
1 Month
+11.99%
6 Months
+102.39%
1 Year
+35.91%

$SGHT stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SGHT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SGHT's directors and management

Net Shares Purchased by Insiders−100k−50k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SGHT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

SGHT Revenue by Segment

$25.61MTotal
Interventional Glaucoma$21.05M82.16%
Interventional Dry Eye$3.88M15.14%
Investment income$692.00K2.70%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New SGHT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SGHT from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in SGHT

IWMiShares Russell 2000 ETF$10.79M
VTIVanguard Morningstar Total Stock Market ETF$8.35M
VXFVanguard Extended Market ETF$4.21M
IWOiShares Russell 2000 Growth ETF$4.00M
SMLFiShares U.S. Small-Cap Equity Factor ETF$2.31M
VTWOVanguard Russell 2000 ETF$2.15M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from SGHT’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
16
Analyst Ratings
32% of score
82
News & Sentiment
20% of score
75

News check: Q3 earnings beat with guidance raise and analyst upgrade from UBS with raised price target drive bullish coverage.

Recent Insider Activity

Buys
1
Sells
19
Buy Value
$68.81K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

DWASInvesco Dorsey Wright SmallCap Momentum ETF0.54%
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.39%
LNGRGlobal X Aging Population ETF0.29%
FSEGFidelity Enhanced Small Cap Growth ETF0.12%
IWCiShares Micro-Cap ETF0.11%
AIMSAcuitas Small Cap Active ETF0.10%
SMLFiShares U.S. Small-Cap Equity Factor ETF0.06%

Weight is the stock’s share of each fund’s holdings.